Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON to present new clinical data and corporate updates at international conferences in...
The conferences are: BioEquity Europe Digital, Foro Medcap BME 2021, Oxford Global’s Online Drug Discovery Week, Jefferies Virtual Healthcare Conference 2021, Precision in Drug Discovery & Preclinical
-
NewAsabys Partners certifies with Bureau Veritas its Social Responsibility Management System...
Asabys, who has been in business for almost 3 years, has considered sustainability as a fundamental pillar of its strategic objectives since inception
-
OfferClinical Study Manager
-
CompanyCool Chain Logistics, SL
-
-
Press releasePrivate investment in Spanish biotech firms up nearly 50% in 2020
This year saw over €150 million in private capital invested, compared to €103 million in 2019. Publicly traded biotech firms attracted over €70 million on capital markets, up 35% from 2019
-
NewORYZON reports results and corporate update for quarter ended March 31, 2021
La compañía invierte 3,6 M€ en I+D sin impactos significativos derivados de la pandemia covid-19
-
New3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new t...
3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications
-
NewYsios Capital invests in Cytoki Pharma
Biotech company Cytoki Pharma (Copenhagen, Denmark) develops new proteins based on interleukin 22 (IL-22) for the treatment of epithelial lesions
-
CompanyBME Growth
-
NewYsios Capital leads a 51 million euros investment in Adcendo
Adcendo (Copenhagen, Denmark), is a biotechnology company specializing in the development of immunoconjugated drugs for the treatment of certain types of cancer that do not respond to current
-
CompanyIllumina
-
CompanyCellab
-
NewFirst AI-designed drug for Huntington’s disease to enter clinical trials
In less than 12 months, the collaboration between Chemotargets, based in the Barcelona Science Park, and Galyan Bio yields a scaffold for first-in-class clinical candidates in difficult area of
-
NewPrivate investment in Spanish biotech firms up nearly 50% in 2020
This year saw over €150 million in private capital invested, compared to €103 million in 2019. Publicly traded biotech firms attracted over €70 million on capital markets, up 35% from 2019
-
-
EventEMBO Practical Course: Flow Cytometry of biological nano-particles for multi-omics analysi...
New flow cytometry strategies allow researchers to address the study of biological nano-particles (BNP) up to the single-particle level.
-
NewIt is now possible to buy COVID-19 rapid selftest with delivery in 24/ 48 h through kitan...
With a reliability close to 100% (CE marking), rapid antigen self-tests become a routine preventive act against COVID-19
-
Press releaseAseBio announces that BIOSPAIN, Spain's leading biotech event, will be held at the end of ...
BIOSPAIN will be held at the Palacio de Congresos y Auditorio de Navarra-Baluarte in Pamplona, from 27 September to 1 October 2021, following a hybrid format
-
Press releaseSpain leads research in advanced therapies with almost 120 clinical trials
Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
-
NewMerck’s contribution in the field of Cultured Meat
Merck has ongoing research lines related to the management of resource scarcity and is driving innovation in the industrial field of 'clean meat' as a healthy, ethical and more planet-friendly